Significant Improvement in Survival after Unrelated Donor Hematopoietic Cell Transplantation in the Recent Era

Patients and physicians may defer unrelated donor hematopoietic cell transplantation (HCT) as curative therapy due to mortality risk associated with the procedure. Therefore, it is important for physicians to know the current outcomes data when counseling potential candidates. To provide this inform...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Biol Blood Marrow Transplant
Autors principals: Majhail, Navneet S, Chitphakdithai, Pintip, Logan, Brent, King, Roberta, Devine, Steven, Rossmann, Susan N, Hale, Gregory, Hartzman, Robert J, Karanes, Chatchada, Laport, Ginna G, Nemecek, Eneida, Snyder, Edward L, Switzer, Galen E, Miller, John, Navarro, Willis, Confer, Dennis L, Levine, John E
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4272902/
https://ncbi.nlm.nih.gov/pubmed/25445638
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2014.10.001
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars